WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO1997040158) EPIMORPHIN ANTAGONIST AND PROCESS FOR PRODUCING THE SAME
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/1997/040158    International Application No.:    PCT/JP1997/001414
Publication Date: 30.10.1997 International Filing Date: 24.04.1997
IPC:
A61K 38/00 (2006.01), C07K 14/475 (2006.01)
Applicants: SUMITOMO ELECTRIC INDUSTRIES, LTD. [JP/JP]; 5-33, Kitahama 4-chome, Chuo-ku, Osaka-shi, Osaka 541 (JP) (For All Designated States Except US).
KOSHIDA, Shogo [JP/JP]; (JP) (For US Only)
Inventors: KOSHIDA, Shogo; (JP)
Agent: HASEGAWA, Yoshiki; Souei International Patent Firm, 6F., Kyobashi National Building, 13-10, Kyobashi 2-chome, Chuo-ku, Tokyo 104 (JP)
Priority Data:
8/102553 24.04.1996 JP
9/10148 23.01.1997 JP
Title (EN) EPIMORPHIN ANTAGONIST AND PROCESS FOR PRODUCING THE SAME
(FR) ANTAGONISTE DE L'EPIMORPHINE ET SON PROCEDE DE FABRICATION
Abstract: front page image
(EN)An epimorphin antagonist comprising a part of the functional domain of epimorphins, e.g., the polypeptide specified by the following amino acid sequence: H-Ser(Asn)-Gly-Asn-Arg-Thr-Ser-Val-Asp-Leu-Arg-Ile-Arg-Arg-Thr-Gln-His-Ser-Val-Leu-OH, and substantially inhibiting the activity of epimorphins of accelerating the morphogenesis of epithelial cells; and a medicine comprising the antagonist as the active ingredient.
(FR)L'invention concerne un antagoniste de l'épimorphine comprenant une partie du domaine fonctionnel des épimorphines, par exemple le polypeptide spécifié par la séquence d'acides aminés suivante: H-Ser(Asn)-Gly-Asn-Arg-Thr-Ser-Val-Asp-Leu-Arg-Ile-Arg-Arg-Thr-Gln-His-Ser-Val-Leu-OH, et inhibant sensiblement l'activité des épimorphines accélérant la morphogénèse des cellules épithéliales; et un médicament contenant comme principe actif ledit antagoniste.
Designated States: US.
European Patent Office (AT, BE, CH, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE).
Publication Language: Japanese (JA)
Filing Language: Japanese (JA)